Skip to main content

Martine Roussel, Ph.D., elected to the AACR Academy Class of 2021

Memphis, Tennessee, March 30, 2021

Researcher in black and white shirt smiles at camera.

Martine Roussel, Ph.D., of Tumor Cell Biology at St. Jude, has been elected to the AACR Academy Class of 2021. 

Martine Roussel, Ph.D., a molecular oncologist at St. Jude Children's Research Hospital, has been elected to the 2021 Class of Fellows of the American Association for Cancer Research. 

Roussel is a member of the Department of Tumor Cell Biology at St. Jude. Her research into childhood brain tumors, conducted over the past fifty years, has led to new avenues of treatments and therapies to maximize cures. She has made landmark findings in molecular oncology, cell cycle control and translational development of treatment strategies for pediatric medulloblastoma.

Fellows of the AACR Academy serve as a global brain trust in the cancer field. They help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

"It is an amazing honor to be elected as a member of a remarkable group of scientists and clinicians committed to advancing cancer treatments," Roussel said.

This year, 25 scientists were elected to the AACR Class of Fellows. All Fellows are nominated and elected through an annual peer review process conducted by existing Fellows of the AACR Academy and ratified by the AACR Academy Steering Committee and AACR Executive Committee. This process involves a rigorous assessment of each candidate’s scientific accomplishments in cancer research and cancer-related sciences. Only individuals whose work has had a significant and enduring impact on cancer research are considered for election and induction into the AACR Academy. 

 “The 2021 class consists of luminaries representing numerous scientific disciplines, whose work has significantly accelerated the pace of progress against various malignancies,” said Margaret Foti, Ph.D., M.D., chief executive officer of the AACR. "We are honored to have them join our 231 existing Fellows and look forward to celebrating their unique scientific achievements.”

Roussel holds the St. Jude Endowed Chair in Molecular Oncogenesis. She has also been elected to the American Academy of Arts and Sciences (2011) and to the National Academy of Sciences (2019).

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.